FATE
Price
$1.27
Change
+$0.02 (+1.60%)
Updated
Jan 17 closing price
Capitalization
144.65M
43 days until earnings call
TSVT
Price
$2.61
Change
+$0.17 (+6.97%)
Updated
Jan 17 closing price
Capitalization
134.65M
65 days until earnings call
Ad is loading...

FATE vs TSVT

Header iconFATE vs TSVT Comparison
Open Charts FATE vs TSVTBanner chart's image
Fate Therapeutics
Price$1.27
Change+$0.02 (+1.60%)
Volume$1.27M
Capitalization144.65M
2seventy bio
Price$2.61
Change+$0.17 (+6.97%)
Volume$380.02K
Capitalization134.65M
FATE vs TSVT Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. TSVT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and TSVT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FATE: $1.27 vs. TSVT: $2.61)
Brand notoriety: FATE and TSVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 32% vs. TSVT: 108%
Market capitalization -- FATE: $144.65M vs. TSVT: $134.65M
FATE [@Biotechnology] is valued at $144.65M. TSVT’s [@Biotechnology] market capitalization is $134.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileTSVT’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • TSVT’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and TSVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while TSVT’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • TSVT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TSVT is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -13.31% price change this week, while TSVT (@Biotechnology) price change was +4.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

FATE is expected to report earnings on Apr 30, 2025.

TSVT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($145M) has a higher market cap than TSVT($135M). TSVT YTD gains are higher at: -11.224 vs. FATE (-23.030). TSVT has higher annual earnings (EBITDA): -133.86M vs. FATE (-177.57M). FATE has more cash in the bank: 297M vs. TSVT (192M). FATE has less debt than TSVT: FATE (99M) vs TSVT (247M). TSVT has higher revenues than FATE: TSVT (45.6M) vs FATE (13.4M).
FATETSVTFATE / TSVT
Capitalization145M135M107%
EBITDA-177.57M-133.86M133%
Gain YTD-23.030-11.224205%
P/E RatioN/AN/A-
Revenue13.4M45.6M29%
Total Cash297M192M155%
Total Debt99M247M40%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATETSVT
RSI
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
87%
Momentum
ODDS (%)
Bearish Trend 6 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
71%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
+1.60%
ALLO - FATE
59%
Loosely correlated
-1.09%
NTLA - FATE
51%
Loosely correlated
+0.85%
CRSP - FATE
50%
Loosely correlated
+0.57%
CRBU - FATE
50%
Loosely correlated
-0.65%
RCKT - FATE
50%
Loosely correlated
+0.98%
More

TSVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSVT has been loosely correlated with KALV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TSVT jumps, then KALV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSVT
1D Price
Change %
TSVT100%
+6.97%
KALV - TSVT
43%
Loosely correlated
+0.61%
AVIR - TSVT
42%
Loosely correlated
+1.20%
ALLO - TSVT
39%
Loosely correlated
-1.09%
ATXS - TSVT
38%
Loosely correlated
-3.23%
FATE - TSVT
37%
Loosely correlated
+1.60%
More